Matches in Nanopublications for { ?s ?p "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1216445.RAveksv5PIWdnSXPKBwh88rpv2QYJGbNkYPox_POkxBVs130_assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216445.RAveksv5PIWdnSXPKBwh88rpv2QYJGbNkYPox_POkxBVs130_provenance.
- NP1216446.RAgKiXT812wY88we0dh23VNhfP7lI6hMmF-qHgqvSA2rk130_assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216446.RAgKiXT812wY88we0dh23VNhfP7lI6hMmF-qHgqvSA2rk130_provenance.
- NP1216441.RA4Pv3DUPMVcq7gDLmcwJ3oPWJ2ry8MRBawsvLIZvVCbo130_assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216441.RA4Pv3DUPMVcq7gDLmcwJ3oPWJ2ry8MRBawsvLIZvVCbo130_provenance.
- NP1216442.RA7zISBxF_lrG0WoDkShu-4p2MMRruOqosxDLZ-vkOQOo130_assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216442.RA7zISBxF_lrG0WoDkShu-4p2MMRruOqosxDLZ-vkOQOo130_provenance.
- NP1216447.RA23zB8SuxSxibTcvA38oP3hn-mD12qP7d0Mt4f_vP8rI130_assertion description "[As the transcriptional coactivator CITED2 (CBP/p300-interacting-transactivator-with-an ED-rich-tail 2) can be overexpressed in acute myeloid leukemia (AML) cells, we analyzed the consequences of high CITED2 expression in normal and AML cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216447.RA23zB8SuxSxibTcvA38oP3hn-mD12qP7d0Mt4f_vP8rI130_provenance.